A. Pergel Et Al. , "Effects of infliximab against carbon tetrachloride-induced intestinal injury via lipid peroxidation and apoptosis," HUMAN & EXPERIMENTAL TOXICOLOGY , vol.38, no.11, pp.1275-1282, 2019
Pergel, A. Et Al. 2019. Effects of infliximab against carbon tetrachloride-induced intestinal injury via lipid peroxidation and apoptosis. HUMAN & EXPERIMENTAL TOXICOLOGY , vol.38, no.11 , 1275-1282.
Pergel, A., TUMKAYA, L., COLAKOGLU, M. K., Demiral, G., Kalcan, S., OZDEMIR, A., ... MERCANTEPE, T.(2019). Effects of infliximab against carbon tetrachloride-induced intestinal injury via lipid peroxidation and apoptosis. HUMAN & EXPERIMENTAL TOXICOLOGY , vol.38, no.11, 1275-1282.
Pergel, AHMET Et Al. "Effects of infliximab against carbon tetrachloride-induced intestinal injury via lipid peroxidation and apoptosis," HUMAN & EXPERIMENTAL TOXICOLOGY , vol.38, no.11, 1275-1282, 2019
Pergel, AHMET Et Al. "Effects of infliximab against carbon tetrachloride-induced intestinal injury via lipid peroxidation and apoptosis." HUMAN & EXPERIMENTAL TOXICOLOGY , vol.38, no.11, pp.1275-1282, 2019
Pergel, A. Et Al. (2019) . "Effects of infliximab against carbon tetrachloride-induced intestinal injury via lipid peroxidation and apoptosis." HUMAN & EXPERIMENTAL TOXICOLOGY , vol.38, no.11, pp.1275-1282.
@article{article, author={AHMET PERGEL Et Al. }, title={Effects of infliximab against carbon tetrachloride-induced intestinal injury via lipid peroxidation and apoptosis}, journal={HUMAN & EXPERIMENTAL TOXICOLOGY}, year=2019, pages={1275-1282} }